Table 3 Cardiometabolic and musculoskeletal outcomes with adjusted between-group differences and quantitative and qualitative inferencesa
From: Evaluation of sit-stand workstations in an office setting: a randomised controlled trial
| Â | Intervention | Control | Adjusted change 0 to 8Â week (95Â % CI)b | Probability (%) the true effect is beneficial / trivial / harmful | Qualitative inference | ||
|---|---|---|---|---|---|---|---|
| Â | Baseline | 8Â week | Baseline | 8Â week | |||
Vascular (n = 24 I, 19 C) | |||||||
 FMD (%) | 5.98 (2.32) | 7.13 (2.42) | 5.88 (2.29) | 6.13 (2.64) | 0.97 (−0.55 to 2.50) | 75/22/3 | Benefit likely |
 cIMT (mm) | 0.62 (0.07) | 0.61 (0.07) | 0.58 (0.08) | 0.57 (0.08) | 0.00 (−0.03 to 0.02) | 13/84/3 | Likely trivial |
 Systolic BP (mmHg) | 119.1 (13.8) | 117.1 (12.5) | 117.9 (12.1) | 117.3 (9.0) | −1.6 (−7.0 to 3.7) | 22/71/7 | Unclear |
 Diastolic BP (mmHg) | 73.5 (7.6) | 68.9 (8.5) | 71.8 (10.7) | 70.5 (9.5) | −2.5 (−7.2 to 2.2) | 62/35/3 | Benefit possible |
Blood (n = 20 I, 17 C) | |||||||
 Glucose (mmol/L) | 5.30 (0.79) | 4.59 (0.84) | 4.85 (0.62) | 4.49 (0.55) | −0.09 (−0.56 to 0.39) | 37/49/14 | Unclear |
 Triglycerides (mmol/L) | 1.65 (0.70) | 1.61 (0.74) | 1.61 (0.64) | 1.65 (0.73) | 0.11 (−0.23 to 0.45) | 6/55/39 | Unclear |
 Cholesterol (mmol/L) | 4.45 (0.98) | 3.79 (1.05) | 3.94 (0.86) | 3.78 (0.74) | −0.40 (−0.79 to −0.003)* | 82/18/0 | Benefit likely |
Musculoskeletal discomfort/painc (n = 25 I, 21 C) | |||||||
 Lower back | 2.5 (2.2) | 1.8 (2.0) | 2.0 (2.0) | 1.7 (1.8) | −0.2 (−1.0 to 0.7) | 35/50/15 | Unclear |
 Upper back | 1.9 (2.3) | 1.1 (1.7) | 1.2 (1.5) | 1.6 (2.3) | −0.9 (−1.9 to 0.2) | 83/16/1 | Benefit likely |
 Neck and shoulder | 2.6 (2.5) | 1.9 (2.4) | 2.1 (2.0) | 2.2 (2.4) | −0.6 (−1.5 to 0.2) | 63/36/1 | Benefit possible |